Detail page

Knowledge Web

Person

Thomas Haberer (1960-)

Physiker

Name	Thomas Haberer
Time	1960- (Date of birth and death)
Place	Heidelberg (Wirkungsort) Deutschland
Academic degree	Prof. Dr.
Profession	Physiker (characteristic profession)
Related	Klinikum Heidelberg (Wissenschaftlich-technischer Direktor des Heidelberger Ionenstrahl-Therapiezentrums) (07/2005-)
Topic	Personen zu Physik
Source	Vorlage
Record type	Person
GND-Identifier	123579198
Record ID	123579198
Involved in show all Biomedical Research Programs at Present and Future High-Energy Particle Accelerators Entwicklung eines Profilmonitors auf Szintillationsfaser-Basis für Ionenstrahlen niedriger Intensität am Heidelberger Ionenstrahl-Therapiezentrum Advancements in the scintillation fibre beam monitor for low-intensity ion beams at HIT How can we consider variable RBE and LETd prediction during clinical practice? A pediatric case report at the Normandy Proton Therapy Centre using an independent dose engine Are Further Cross Section Measurements Necessary for Space Radiation Protection or Ion Therapy Applications? Helium Projectiles Roadmap: helium ion therapy South East European International Institute for Sustainable Technologies (SEEIIST) Biophysical modeling and experimental validation of relative biological effectiveness (RBE) for 4He ion beam therapy Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison Fast robust dose calculation on GPU for high-precision 1H, 4He, 12C and 16O ion therapy: the FRoG platform Proton and helium ion radiotherapy for meningioma tumors: a Monte Carlo-based treatment planning comparison Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel Treatment of arrhythmias by external charged particle beams: a Langendorff feasibility study Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro Preclinical investigations towards the first spacer gel application in prostate cancer treatment during particle therapy at HIT Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response Identification of stable endogenous control genes for transcriptional profiling of photon, proton and carbon-ion irradiated cells Monitoring of patients treated with particle therapy using positron-emission-tomography (PET): the MIRANDA study Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial Entwicklung eines magnetischen Strahlführungssystems zur tumorkonformen Strahlentherapie mit schweren geladenen Teilchen Entwicklung eines magnetischen Strahlführungssystems zur tumorkonformen Strahlentherapie mit schweren geladenen Teilchen

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Thomas Haberer (1960-)

Biomedical Research Programs at Present and Future High-Energy Particle Accelerators

Entwicklung eines Profilmonitors auf Szintillationsfaser-Basis für Ionenstrahlen niedriger Intensität am Heidelberger Ionenstrahl-Therapiezentrum

Advancements in the scintillation fibre beam monitor for low-intensity ion beams at HIT

How can we consider variable RBE and LETd prediction during clinical practice? A pediatric case report at the Normandy Proton Therapy Centre using an independent dose engine

Are Further Cross Section Measurements Necessary for Space Radiation Protection or Ion Therapy Applications? Helium Projectiles

Roadmap: helium ion therapy

South East European International Institute for Sustainable Technologies (SEEIIST)

Biophysical modeling and experimental validation of relative biological effectiveness (RBE) for 4He ion beam therapy

Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison

Fast robust dose calculation on GPU for high-precision 1H, 4He, 12C and 16O ion therapy: the FRoG platform

Proton and helium ion radiotherapy for meningioma tumors: a Monte Carlo-based treatment planning comparison

Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation

Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma

Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel

Treatment of arrhythmias by external charged particle beams: a Langendorff feasibility study

Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel

Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro

Preclinical investigations towards the first spacer gel application in prostate cancer treatment during particle therapy at HIT

Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response

Identification of stable endogenous control genes for transcriptional profiling of photon, proton and carbon-ion irradiated cells

Monitoring of patients treated with particle therapy using positron-emission-tomography (PET): the MIRANDA study

Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts

In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells

Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial

Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial

Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial

Entwicklung eines magnetischen Strahlführungssystems zur tumorkonformen Strahlentherapie mit schweren geladenen Teilchen

Entwicklung eines magnetischen Strahlführungssystems zur tumorkonformen Strahlentherapie mit schweren geladenen Teilchen